Home  >  Companies  >  Alloy Therapeutics Alloy Therapeutics Follow Drug discovery platform and services for antibody, TCR mimic, and oligonucleotide therapeutics #biotechnology Valuation $1.00B 2026 Funding $136.24M 2022 Details Headquarters Boston, United States CEO Errik Anderson Website alloytx.com Milestones FOUNDING YEAR 2017 Listed In #biotechnology Alloy Therapeutics Overview Metrics News Filings Filings Company documents and regulatory filings for Alloy Therapeutics. Name Type Filed At Actions Form D — 0001851943-26-000001 Form D Apr 15, 2026 View PDF Form D — 0001851943-22-000001 Form D Oct 03, 2022 View PDF Form D — 0001851943-21-000001 Form D Apr 02, 2021 View PDF